Crossref
Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients
American Journal of Biomedical Sciences · 2022-04 · 58-71
DOI: 10.5099/aj220200058 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biomedical Sciences, 2022-04. Verfasst von Jasmeet Kaur. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kaur, J. (2022). Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients. American Journal of Biomedical Sciences, 58-71. https://doi.org/10.5099/aj220200058
Vancouver
Kaur J. Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients. American Journal of Biomedical Sciences. 2022:58-71. doi:10.5099/aj220200058
BibTeX
@article{Kaur2022,
author = {Kaur, Jasmeet},
title = {Prognostic Effect of Glycogen Synthase Kinase 3A (GSK3A) mRNA Expression in Breast Cancer Patients},
journal = {American Journal of Biomedical Sciences},
year = {2022},
pages = {58--71},
doi = {10.5099/aj220200058}
}
EUVIMED